Findings

What do systematic reviews say?

16 questions · 17 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 1 · 5.9%GRADE not reported 0 · 0%Very low 3 · 17.6%Low 9 · 52.9%Moderate 3 · 17.6%High 1 · 5.9%

MgSO4 + SABA vs SABA

PEF (L/min) · adults and children with acute exacerbation of asthma

2 findings from 1 review

Inhaled magnesium sulfate in the treatment of acute asthma 2017 · Cochrane Headline outcomes only
no estimate extracted
1 study · 80 participants
Low
Inhaled magnesium sulfate in the treatment of acute asthma 2017 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 155 participants
Low

MgSO4 + SABA vs SABA

Admission to hospital at initial presentation · adults and children with acute exacerbation of asthma

MgSO4 + SABA showed no clear difference in admission to hospital at initial presentation compared with SABA (low certainty).

1 finding from 1 review

Inhaled magnesium sulfate in the treatment of acute asthma 2017 · Cochrane Headline outcomes only
RR 0.78 [0.52, 1.15]
6 studies · 375 participants
Low

MgSO4 + SABA vs SABA

Serious adverse events (During ED/hospital admission) · adults and children with acute exacerbation of asthma

1 finding from 1 review

Inhaled magnesium sulfate in the treatment of acute asthma 2017 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 243 participants
Low

MgSO4 + SABA vs SABA

Any adverse events (During ED/hospital admission) · adults and children with acute exacerbation of asthma

1 finding from 1 review

Inhaled magnesium sulfate in the treatment of acute asthma 2017 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 694 participants
Low

MgSO4 + SABA vs SABA

FEV1 % predicted · adults and children with acute exacerbation of asthma

1 finding from 1 review

Inhaled magnesium sulfate in the treatment of acute asthma 2017 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 208 participants
Low

MgSO4 + SABA + ipratropium vs SABA + ipratropium

FEV1 · adults and children with acute exacerbation of asthma

1 finding from 1 review

Inhaled magnesium sulfate in the treatment of acute asthma 2017 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 120 participants
Very low

MgSO4 + SABA + ipratropium vs SABA + ipratropium

Pulmonary function % predicted PEF (60 minutes) · adults and children with acute exacerbation of asthma

1 finding from 1 review

Inhaled magnesium sulfate in the treatment of acute asthma 2017 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 636 participants
Moderate

MgSO4 + SABA + ipratropium vs SABA + ipratropium

Clinical severity scores (60 minutes) · adults and children with acute exacerbation of asthma

1 finding from 1 review

Inhaled magnesium sulfate in the treatment of acute asthma 2017 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 1130 participants
Low

MgSO4 + SABA + ipratropium vs SABA + ipratropium

Admission to hospital at initial presentation · adults and children with acute exacerbation of asthma

MgSO4 + SABA + ipratropium showed no clear difference in admission at first presentation compared with SABA + ipratropium (moderate certainty).

1 finding from 1 review

Inhaled magnesium sulfate in the treatment of acute asthma 2017 · Cochrane Headline outcomes only
RR 0.95 [0.91, 1]
4 studies · 1308 participants
Moderate

MgSO4 + SABA + ipratropium vs SABA + ipratropium

Patient readmissions · adults and children with acute exacerbation of asthma

MgSO4 + SABA + ipratropium showed no clear difference in readmission (7 to 30 days) compared with SABA + ipratropium (low certainty).

1 finding from 1 review

Inhaled magnesium sulfate in the treatment of acute asthma 2017 · Cochrane Headline outcomes only
RR 1.8 [0.84, 3.87]
2 studies · 750 participants
Low

MgSO4 + SABA + ipratropium vs SABA + ipratropium

Serious adverse events (during admission) · adults and children with acute exacerbation of asthma

1 finding from 1 review

Inhaled magnesium sulfate in the treatment of acute asthma 2017 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 557 participants
Moderate

MgSO4 + SABA + ipratropium vs SABA + ipratropium

Adverse effects Defined as any adverse event occurring post‐admission · adults and children with acute exacerbation of asthma

1 finding from 1 review

Inhaled magnesium sulfate in the treatment of acute asthma 2017 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 1197 participants
High

MgSO4 vs SABA

Lung function · adults and children with acute exacerbation of asthma

The review found no eligible studies for this question.

1 finding from 1 review

Inhaled magnesium sulfate in the treatment of acute asthma 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

MgSO4 vs SABA

Clinical severity score ‐ Fischl index (120 minutes) · adults and children with acute exacerbation of asthma

1 finding from 1 review

Inhaled magnesium sulfate in the treatment of acute asthma 2017 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 93 participants
Very low

MgSO4 vs SABA

Admission to hospital at initial presentation · adults and children with acute exacerbation of asthma

It is very uncertain whether mgSO4 changes admission to hospital at initial presentation compared with SABA (very low certainty).

1 finding from 1 review

Inhaled magnesium sulfate in the treatment of acute asthma 2017 · Cochrane Headline outcomes only
RR 0.53 [0.05, 5.31]
1 study · 33 participants
Very low

MgSO4 vs SABA

Serious adverse events (During ED/hospital admission) · adults and children with acute exacerbation of asthma

1 finding from 1 review

Inhaled magnesium sulfate in the treatment of acute asthma 2017 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 53 participants
Low